Almasry Pharmacy

Insulin Mixtard 100Unit

Short Description:
Insulin Mixtard 100Unit is a human insulin injection used to control high blood sugar in adults and children with type 1 and type 2 diabetes. It supports stable glycemic control, helping to prevent acute and long‑term diabetes complications when used as part of a comprehensive treatment plan including diet and exercise.

EGP 130

In Stock

delivery-iconDelivery to governorates within 3-4 working days
refund-iconEasy returns within 14 days
Specifications
SKUISG003517
BrandInsulinLink Icon
Categories
Medication & Treatments
Color
black
Shop by ConcernsDiabetesLink Icon, High Blood SugarLink Icon, HyperglycemiaLink Icon
Gender
Neutral
Shop By GoalsBlood ThinningLink Icon, Diabetes ManagementLink Icon, Glycemic ControlLink Icon
Ingredient
Insulin human
UPC
6222003410202
Specialty
Clinically Tested
Prescription only
Sub Categories
Insulin And Diabetic Medicines
Warning
Do not use during hypoglycemic episodes
Monitor blood glucose
Use under medical supervision only
Risk of hypoglycemia
About the product

Insulin Mixtard 100Unit

Description:

Insulin Mixtard 100Unit is a prescription antidiabetic medicine used for the management of diabetes mellitus. It is a human insulin preparation designed to help control high blood glucose levels in adults and children with type 1 and type 2 diabetes, as an adjunct to diet and exercise. By replacing or supplementing the body’s own insulin, it supports proper glucose uptake into tissues and helps prevent both short‑term and long‑term complications of diabetes such as hyperglycemia, ketoacidosis, and vascular damage.


Indications:

  • Indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 1 diabetes mellitus.
  • Indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus requiring insulin therapy.
  • Management of fasting and post‑prandial hyperglycemia.
  • Prevention of acute diabetic complications related to uncontrolled blood glucose, such as diabetic ketoacidosis and hyperosmolar states (as part of a comprehensive treatment plan).

Active Ingredients / Key Components:

  • Insulin human (recombinant human insulin) – 100 unit/ml (exact mixture ratio of short‑acting and intermediate‑acting components is not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.)).
  • Other excipients: information on additional inactive ingredients (e.g. preservatives, stabilizers) is not available in the provided data.

Dosage & Administration / How to Use:

  • Dosage is individualized based on the patient’s metabolic needs, blood glucose monitoring results, type of diabetes, diet, and level of physical activity. Always follow your doctor’s exact prescription.
  • Insulin Mixtard 100Unit is administered by subcutaneous injection. The specific injection sites (abdomen, thigh, upper arm, or buttock) should be rotated to reduce the risk of lipodystrophy.
  • It is usually given once or twice daily, depending on the regimen prescribed by the healthcare provider. Timing is generally in relation to meals to control both fasting and post‑meal blood glucose; follow your doctor’s instructions on injection timing.
  • Do not inject intramuscularly or intravenously unless specifically instructed by a healthcare professional.
  • Check the insulin visually before use. Do not use if the solution appears discolored, contains particles, or has been frozen.
  • Use an appropriate insulin syringe or insulin delivery device compatible with 100 unit/ml insulin, as instructed by your healthcare provider.
  • Never share insulin vials, pens, or needles with others to prevent infection transmission.
  • Monitor blood glucose regularly as advised and report any unexplained hypo‑ or hyperglycemic episodes to your doctor for dose adjustment.

Clinical Benefits:

  • Helps achieve and maintain better glycemic control in patients with type 1 and type 2 diabetes mellitus.
  • Supports regulation of glucose metabolism by promoting glucose uptake into muscle and adipose tissue and inhibiting hepatic glucose production.
  • Reduces the risk of acute complications of diabetes such as severe hyperglycemia and diabetic ketoacidosis when used as prescribed.
  • Contributes to the long‑term prevention of diabetes‑related microvascular and macrovascular complications (e.g. neuropathy, nephropathy, retinopathy, cardiovascular disease) as part of a comprehensive diabetes management plan.

Warnings & Contraindications:

  • For subcutaneous use only unless otherwise directed by a healthcare professional. Incorrect route of administration may cause severe hypoglycemia.
  • Do not use during episodes of hypoglycemia (low blood sugar). Treat hypoglycemia first as per medical advice.
  • Use with extreme caution in patients with renal or hepatic impairment; dose adjustment and close monitoring may be required.
  • Concomitant use with other antidiabetic medicines (such as oral hypoglycemic agents, GLP‑1 agonists, SGLT2 inhibitors) requires careful monitoring to avoid hypoglycemia.
  • Changes in insulin type, strength, manufacturer, or regimen must be done only under medical supervision, with close blood glucose monitoring.
  • Alcohol intake may enhance the hypoglycemic effect and should be limited or avoided.
  • Beta‑blockers and some other medicines may mask symptoms of hypoglycemia; inform your doctor about all medications you are taking.
  • Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding; insulin requirements may change during pregnancy and postpartum.
  • Patients should be educated on recognizing and managing hypoglycemia and hyperglycemia, and on proper injection technique.
  • Keep out of reach of children.

Side Effects:
  • Common: Hypoglycemia (sweating, tremor, palpitations, hunger, headache, dizziness, confusion). This is the most frequent and potentially serious side effect; treat immediately according to your doctor’s instructions.
  • Local injection site reactions: redness, swelling, itching, or pain at the injection site; usually mild and transient.
  • Lipodystrophy (lipoatrophy or lipohypertrophy) at injection sites with repeated injections in the same area; rotate injection sites to minimize this risk.
  • Allergic reactions: rash, pruritus, or more rarely generalized allergic reactions. Seek medical attention if you experience widespread rash, difficulty breathing, or swelling of the face, lips, or throat.
  • Edema or fluid retention may occur in some patients when initiating or intensifying insulin therapy.
  • Seek immediate medical attention if you experience severe or recurrent hypoglycemia, loss of consciousness, seizures, or signs of severe allergic reaction.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.


Specifications:
  • Product type: Prescription antidiabetic medicine (insulin preparation).
  • Strength: 100 unit/ml.
  • Product form: Solution for injection in vial (exact vial volume not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.)).
  • Suitable for: Adults and children with type 1 or type 2 diabetes mellitus, as prescribed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.

Product Reviews

Overall Rating
0

Based on 0 reviews

Warning iconYou can add a rating once you purchase the product through the My Orders page

Customer Reviews
No reviews yet
TelegramWhatsApp